Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Vascular Biology

Background:

• End-stage renal disease (ESRD) is associated with high cardiovascular mortality.
• Atherosclerosis, characterized by arterial calcification and aortic stiffness, is a primary driver of this mortality.
• These arterial changes impair arterial function, increasing cardiovascular risk.

Purpose of the Study:

• To highlight the contribution of large artery damage to cardiovascular mortality in ESRD.
• To underscore the prognostic value of arterial calcification and aortic stiffness in ESRD.
• To evaluate the impact of treatments on blood pressure and aortic stiffness in ESRD survival.

Main Methods:

• Review of epidemiological and clinical studies on ESRD patients.
• Analysis of the relationship between atherosclerosis, arterial calcification, aortic stiffness, and cardiovascular outcomes.
• Assessment of treatment effects on blood pressure, aortic stiffness, and survival.

Main Results:

• Arterial calcification and aortic stiffness are independent predictors of mortality in ESRD.
• Treatments reducing blood pressure and aortic stiffness significantly improve survival in ESRD patients, independent of blood pressure.
• Microinflammation and elevated C-reactive protein may limit treatment response.

Conclusions:

• Damage to large arteries, specifically atherosclerosis and aortic stiffness, is a critical factor in cardiovascular mortality among ESRD patients.
• Interventions aimed at improving arterial health and reducing stiffness offer a promising survival benefit in ESRD.
• Inflammatory status is a crucial consideration for optimizing treatment efficacy in this population.